Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason ...

Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

Drugmakers blame middlemen known as pharmacy benefit managers for high drug prices. PBMs negotiate drug prices and rebates ...

In recent years, many patients like Mitchell have faced soaring insulin costs. These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers and ...

The FTC accuses major PBMs of inflating insulin prices ... PBMs have long been seen as the “middlemen” getting in the way of lower drug prices, with negotiations often resulting in cheaper ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...

Kamala Harris and Donald Trump are both pledging to make health care more affordable in the U.S., but have largely different ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company ...

Ben Hargreaves looks at why insulin ... drug pricing bill fails to take a holistic approach to addressing a system that drives affordability challenges for patients. By taking steps to hold ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...